Abstract:
A method for preparing cefpodoxime proxetil is provided to remove a remaining solvent nearly or completely by carrying out the drying process by using supercritical and subcritical carbon dioxide. A method for preparing cefpodoxime proxetil comprises the step of drying it by using the supercritical and subcritical carbon dioxide at a temperature of 0-70 deg.C and at a pressure of 35-600 atm. to remove the remaining organic solvent.
Abstract:
Acetaminophen fine particles are provided to control the crystal polymorphism of drug by diversifying parameters in manufacturing the particles and to be usable for an immediate release analgesic composition due to improved elution rate. A method for manufacturing acetaminophen fine particles comprises (a) a step for preparing the solution by dissolving acetaminophen in ethylacetate or tetrahydrofurane; (b) a step for preparing the acetaminophen fine particles by mixing carbon dioxide of 0-45 °C and 35-200 pressure(atm) and the solution obtained from the (a) step in a precipitator; (c) a step for removing an organic solvent remaining in particles by using the supercritical carbon dioxide of 0-45 °C and 35-200 pressure(atm); and (d) a step for collecting the fine particles generated through the pressure reduction of the inside of the precipitator.
Abstract:
A method for drying cefpodoxime proxetil is provided to obtain the cefpodoxime proxetil with almost no remaining solvent with reduced cost and drying time by performing a drying process using a saturated liquid CO2, which is relatively cheap, harmless to human body and non-reactive with a product. A method for drying cefpodoxime proxetil comprises a step of removing at least one remaining organic solvent selected from the group consisting of diisopropylether, ethyl acetate and dichloromethane by circulating saturated liquid carbon dioxide using a reboiler and a condenser without using a power unit such as a pump during a process of preparing the cefpodoxime proxetil.